Brepocitinib Interest Gains Momentum in Idiopathic Inflammatory Myopathies as Rheumatologists Signal Readiness for Targeted, Steroid-Sparing Therapies

Keyword: Oral Administration

Publisher: GlobeNewswire

Published: May 28, 2026

Exton, PA, May 28, 2026 (GLOBE NEWSWIRE) -- Spherix Global Insights has released the 2026 update of Market Dynamix: Idiopathic Inflammatory Myopathies (IIM), US, revealing a market increasingly poise… [+7256 chars]

Read Full Story ↗